Follow
Naveed Sattar
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
157092014
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and …
B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ...
European heart journal 39 (33), 3021-3104, 2018
108722018
2016 European Guidelines on cardiovascular disease prevention in clinical practice
MF Piepoli, AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, ...
Kardiologia Polska (Polish Heart Journal) 74 (9), 821-936, 2016
91522016
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and …
F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ...
European heart journal 41 (2), 255-323, 2020
5649*2020
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
Emerging Risk Factors Collaboration
The lancet 375 (9733), 2215-2222, 2010
49202010
Genetic studies of body mass index yield new insights for obesity biology
AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ...
Nature 518 (7538), 197-206, 2015
40222015
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ...
The Lancet 375 (9716), 735-742, 2010
29712010
Major lipids, apolipoproteins, and risk of vascular disease
R Assessment
Jama 302 (18), 1993-2000, 2009
27582009
Diabetes mellitus, fasting glucose, and risk of cause-specific death
Emerging Risk Factors Collaboration
New England Journal of Medicine 364 (9), 829-841, 2011
24682011
Cardiovascular and renal outcomes with empagliflozin in heart failure
M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ...
New England Journal of Medicine 383 (15), 1413-1424, 2020
24342020
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ...
The Lancet 388 (10046), 776-786, 2016
21142016
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
MJL Peters, DPM Symmons, D McCarey, BAC Dijkmans, P Nicola, ...
Annals of the rheumatic diseases 69 (2), 325-331, 2010
20582010
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
N Sattar, A Gaw, O Scherbakova, I Ford, DSJ O’Reilly, SM Haffner, C Isles, ...
Circulation 108 (4), 414-419, 2003
20582003
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, ...
The Lancet 373 (9677), 1765-1772, 2009
17602009
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
17442011
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with …
FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ...
European heart journal 42 (34), 3227-3337, 2021
15122021
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
MEJ Lean, WS Leslie, AC Barnes, N Brosnahan, G Thom, L McCombie, ...
The Lancet 391 (10120), 541-551, 2018
13972018
Empagliflozin in heart failure with a preserved ejection fraction
SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ...
New England Journal of Medicine 385 (16), 1451-1461, 2021
13792021
Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis
N Sattar, DW McCarey, H Capell, IB McInnes
Circulation 108 (24), 2957-2963, 2003
13292003
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
DJ Freeman, J Norrie, N Sattar, RDG Neely, SM Cobbe, I Ford, C Isles, ...
Circulation 103 (3), 357-362, 2001
12392001
The system can't perform the operation now. Try again later.
Articles 1–20